June 10, 2013
Gilead Sciences to Present at the Goldman Sachs 34th Annual Healthcare Conference on Tuesday, June 11
Webcast Available Through Gilead Corporate Website
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jun. 10, 2013--
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate
presentation will be webcast from the Goldman Sachs 34th
Annual Healthcare Conference in Rancho Palos Verdes, California.
Kevin Young CBE, Gilead’s Executive Vice President, Commercial
Operations, will provide an overview of the company at the conference on
Tuesday, June 11 at 10:40 a.m. Pacific Time.
To access the live webcast or a replay via the internet log on to www.gilead.com.
Please connect to the company’s website at least 15 minutes prior to the
start of the presentation to ensure adequate time for any software
download that may be necessary to listen to the webcast. The replay will
be available for 14 days following the presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases worldwide. Headquartered in Foster City,
California, Gilead has operations in North America, Europe and Asia
Pacific.
For more information on Gilead Sciences, please visit www.gilead.com
or call the Gilead Public Affairs Department at 1-800-GILEAD-5
(1-800-445-3235).
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Investor
Relations
